Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Mar 17;63(6):613–615. doi: 10.1136/ard.2003.015586

Autoantibodies and thrombophilia in RA: TNFα and TNFα blockers

G Ferraccioli 1, E Gremese 1
PMCID: PMC1755038  PMID: 15028556

Full Text

The Full Text of this article is available as a PDF (63.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alkaabi J. K., Ho M., Levison R., Pullar T., Belch J. J. F. Rheumatoid arthritis and macrovascular disease. Rheumatology (Oxford) 2003 Feb;42(2):292–297. doi: 10.1093/rheumatology/keg083. [DOI] [PubMed] [Google Scholar]
  2. Anderson Hope D. I., Rahmutula Dolkun, Gardner David G. Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem. 2003 Oct 27;279(2):963–969. doi: 10.1074/jbc.M309552200. [DOI] [PubMed] [Google Scholar]
  3. Arend W. P., Dayer J. M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 1995 Feb;38(2):151–160. doi: 10.1002/art.1780380202. [DOI] [PubMed] [Google Scholar]
  4. Beutler B., Mahoney J., Le Trang N., Pekala P., Cerami A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med. 1985 May 1;161(5):984–995. doi: 10.1084/jem.161.5.984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bickerstaff M. C., Botto M., Hutchinson W. L., Herbert J., Tennent G. A., Bybee A., Mitchell D. A., Cook H. T., Butler P. J., Walport M. J. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med. 1999 Jun;5(6):694–697. doi: 10.1038/9544. [DOI] [PubMed] [Google Scholar]
  6. Blank Miri, Krause Ilan, Fridkin Mati, Keller Nathan, Kopolovic Juri, Goldberg Iris, Tobar Ana, Shoenfeld Yehuda. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest. 2002 Mar;109(6):797–804. doi: 10.1172/JCI12337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bonnet C., Vergne P., Bertin P., Treves R., Jauberteau M. O. antiphospholipid antibodies and RA: presence of beta2GP1 independent aCL. Ann Rheum Dis. 2001 Mar;60(3):303–304. doi: 10.1136/ard.60.3.303a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cambien Beatrice, Bergmeier Wolfgang, Saffaripour Simin, Mitchell Heather A., Wagner Denisa D. Antithrombotic activity of TNF-alpha. J Clin Invest. 2003 Nov;112(10):1589–1596. doi: 10.1172/JCI19284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chung Eugene S., Packer Milton, Lo Kim Hung, Fasanmade Adedigbo A., Willerson James T., Anti-TNF Therapy Against Congestive Heart Failure Investigators Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation. 2003 Jun 9;107(25):3133–3140. doi: 10.1161/01.CIR.0000077913.60364.D2. [DOI] [PubMed] [Google Scholar]
  10. Devaraj Sridevi, Xu Dan Yan, Jialal Ishwarlal. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003 Jan 28;107(3):398–404. doi: 10.1161/01.cir.0000052617.91920.fd. [DOI] [PubMed] [Google Scholar]
  11. Dewberry R., Holden H., Crossman D., Francis S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2394–2400. doi: 10.1161/01.atv.20.11.2394. [DOI] [PubMed] [Google Scholar]
  12. Engström Gunnar, Stavenow Lars, Hedblad Bo, Lind Peter, Eriksson Karl-Fredrik, Janzon Lars, Lindgärde Folke. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes. 2003 Feb;52(2):442–447. doi: 10.2337/diabetes.52.2.442. [DOI] [PubMed] [Google Scholar]
  13. Feldmann M., Brennan F. M., Maini R. N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440. doi: 10.1146/annurev.immunol.14.1.397. [DOI] [PubMed] [Google Scholar]
  14. Ferraccioli G. F., Assaloni R., Di Poi E., Gremese E., De Marchi G., Fabris M. Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial. Rheumatology (Oxford) 2002 Oct;41(10):1109–1112. doi: 10.1093/rheumatology/41.10.1109. [DOI] [PubMed] [Google Scholar]
  15. Ferraccioli G., Mecchia F., Di Poi E., Fabris M. Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections. Ann Rheum Dis. 2002 Apr;61(4):358–361. doi: 10.1136/ard.61.4.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Galli Monica, Luciani Davide, Bertolini Guido, Barbui Tiziano. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2002 Oct 3;101(5):1827–1832. doi: 10.1182/blood-2002-02-0441. [DOI] [PubMed] [Google Scholar]
  17. Honjo Megumi, Nakamura Kayo, Yamashiro Kenji, Kiryu Junichi, Tanihara Hidenobu, McEvoy Leslie M., Honda Yoshihito, Butcher Eugene C., Masaki Tomoh, Sawamura Tatsuya. Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc Natl Acad Sci U S A. 2003 Jan 21;100(3):1274–1279. doi: 10.1073/pnas.0337528100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hänsel Sven, Lässig Grit, Pistrosch Frank, Passauer Jens. Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity. Atherosclerosis. 2003 Sep;170(1):177–180. doi: 10.1016/s0021-9150(03)00281-8. [DOI] [PubMed] [Google Scholar]
  19. Hürlimann David, Forster Adrian, Noll Georg, Enseleit Frank, Chenevard Rémy, Distler Oliver, Béchir Markus, Spieker Lukas E., Neidhart Michel, Michel Beat A. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002 Oct 22;106(17):2184–2187. doi: 10.1161/01.cir.0000037521.71373.44. [DOI] [PubMed] [Google Scholar]
  20. Kwon Hyon J., Coté Timothy R., Cuffe Michael S., Kramer Judith M., Braun M. Miles. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med. 2003 May 20;138(10):807–811. doi: 10.7326/0003-4819-138-10-200305200-00008. [DOI] [PubMed] [Google Scholar]
  21. Laakso M. Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med. 2001 Mar;249(3):225–235. doi: 10.1046/j.1365-2796.2001.00789.x. [DOI] [PubMed] [Google Scholar]
  22. Ley K., Huo Y. VCAM-1 is critical in atherosclerosis. J Clin Invest. 2001 May;107(10):1209–1210. doi: 10.1172/JCI13005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Libby Peter. Inflammation in atherosclerosis. Nature. 2002 Dec 19;420(6917):868–874. doi: 10.1038/nature01323. [DOI] [PubMed] [Google Scholar]
  24. Lipsky P. E., van der Heijde D. M., St Clair E. W., Furst D. E., Breedveld F. C., Kalden J. R., Smolen J. S., Weisman M., Emery P., Feldmann M. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000 Nov 30;343(22):1594–1602. doi: 10.1056/NEJM200011303432202. [DOI] [PubMed] [Google Scholar]
  25. Macik B. G., Rand J. H., Konkle B. A. Thrombophilia: what's a practitioner to do? Hematology Am Soc Hematol Educ Program. 2001:322–338. doi: 10.1182/asheducation-2001.1.322. [DOI] [PubMed] [Google Scholar]
  26. Merkel P. A., Chang Y., Pierangeli S. S., Convery K., Harris E. N., Polisson R. P. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med. 1996 Dec;101(6):576–583. doi: 10.1016/s0002-9343(96)00335-x. [DOI] [PubMed] [Google Scholar]
  27. Nagase M., Abe J., Takahashi K., Ando J., Hirose S., Fujita T. Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. J Biol Chem. 1998 Dec 11;273(50):33702–33707. doi: 10.1074/jbc.273.50.33702. [DOI] [PubMed] [Google Scholar]
  28. Paul E., Carroll M. C. SAP-less chromatin triggers systemic lupus erythematosus. Nat Med. 1999 Jun;5(6):607–608. doi: 10.1038/9450. [DOI] [PubMed] [Google Scholar]
  29. Pepys M. B., Booth S. E., Tennent G. A., Butler P. J., Williams D. G. Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli. Clin Exp Immunol. 1994 Jul;97(1):152–157. doi: 10.1111/j.1365-2249.1994.tb06594.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Platt N., Gordon S. Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. J Clin Invest. 2001 Sep;108(5):649–654. doi: 10.1172/JCI13903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999 Jan 14;340(2):115–126. doi: 10.1056/NEJM199901143400207. [DOI] [PubMed] [Google Scholar]
  32. Seriolo B., Fasciolo D., Sulli A., Cutolo M. Homocysteine and antiphospholipid antibodies in rheumatoid arthritis patients: relationships with thrombotic events. Clin Exp Rheumatol. 2001 Sep-Oct;19(5):561–564. [PubMed] [Google Scholar]
  33. Sherer Y., Shoenfeld Y. Atherosclerosis. Ann Rheum Dis. 2002 Feb;61(2):97–99. doi: 10.1136/ard.61.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Shimaoka T., Kume N., Minami M., Hayashida K., Sawamura T., Kita T., Yonehara S. LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria. J Immunol. 2001 Apr 15;166(8):5108–5114. doi: 10.4049/jimmunol.166.8.5108. [DOI] [PubMed] [Google Scholar]
  35. Solomon Daniel H., Karlson Elizabeth W., Rimm Eric B., Cannuscio Carolyn C., Mandl Lisa A., Manson JoAnn E., Stampfer Meir J., Curhan Gary C. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003 Mar 11;107(9):1303–1307. doi: 10.1161/01.cir.0000054612.26458.b2. [DOI] [PubMed] [Google Scholar]
  36. Thompson D., Pepys M. B., Wood S. P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure. 1999 Feb 15;7(2):169–177. doi: 10.1016/S0969-2126(99)80023-9. [DOI] [PubMed] [Google Scholar]
  37. Via C. S., Shustov A., Rus V., Lang T., Nguyen P., Finkelman F. D. In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL. J Immunol. 2001 Dec 15;167(12):6821–6826. doi: 10.4049/jimmunol.167.12.6821. [DOI] [PubMed] [Google Scholar]
  38. Vittecoq O., Jouen-Beades F., Krzanowska K., Bichon-Tauvel I., Menard J. F., Daragon A., Gilbert D., Tron F., Le Loët X. Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis. Rheumatology (Oxford) 2000 May;39(5):481–489. doi: 10.1093/rheumatology/39.5.481. [DOI] [PubMed] [Google Scholar]
  39. Weinblatt M. E., Kremer J. M., Bankhurst A. D., Bulpitt K. J., Fleischmann R. M., Fox R. I., Jackson C. G., Lange M., Burge D. J. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999 Jan 28;340(4):253–259. doi: 10.1056/NEJM199901283400401. [DOI] [PubMed] [Google Scholar]
  40. Wolfe F., Mitchell D. M., Sibley J. T., Fries J. F., Bloch D. A., Williams C. A., Spitz P. W., Haga M., Kleinheksel S. M., Cathey M. A. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994 Apr;37(4):481–494. doi: 10.1002/art.1780370408. [DOI] [PubMed] [Google Scholar]
  41. Wong M. L., Xie B., Beatini N., Phu P., Marathe S., Johns A., Gold P. W., Hirsch E., Williams K. J., Licinio J. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8681–8686. doi: 10.1073/pnas.150098097. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES